It should be used with caution in dogs with renal or hepatic impairment.
Adequan for dogs with kidney disease.
It is an injectable polysulfated glycosaminoglycan psgag and is the only fda approved product of its type.
Adverse reactions in clinical studies transient pain at injection site transient diarrhea and abnormal bleeding were mild and self limiting.
Adequan canine indications and usage adequan canine is recommended for intramuscular injection for the control of signs associated with non infectious degenerative and or traumatic arthritis of canine synovial joints.
Do not use in dogs.
Important safety information adequan canine should not be used in dogs who are hypersensitive to psgag or who have a known or suspected bleeding disorder.
Yes adequan is delivered as an injection.
Adequan has been clinically shown to help treat the disease while giving relief from pain.
It goes in the muscle.
At least 34 beagles died to prove the safety of my dog s arthritis medicine i recently learned that a study of the arthritis drug adequan unnecessarily euthanized its subjects.
Kidneys also help control blood pressure aid in calcium metabolism and sustain phosphorous levels.
Adequan canine for dogs is used to control symptoms associated with degenerative or traumatic arthritis.
1 after the initial series veterinarians and owners should work together to keep monitoring the dog s joint health and.
They maintain normal concentrations of salt and water in the body.
However note that adequan has not been tested on pregnant or nursing dogs and should be used with caution in dogs that have had liver or kidney transplants or have a history of bleeding abnormalities.
Psgag is a synthetic heparinoid.
What is adequan canine.
Although such treatment is considered off label because it differs from the manufacturer s protocol some veterinarians continue to give adequan injections at monthly intervals or.
If you re unsure always check with your vet.
Just like human kidneys your dog s kidneys balance certain substances in the blood and filter out the body s wastes as urine.
At early signs of oa or degenerative joint disease djd veterinarians can prescribe adequan canine polysulfated glycosaminoglycan at the approved dose to help slow the disease progression with the expectation of achieving the same results shown in clinical studies.
Adequan should not be used in dogs showing hypersensitivity to psgag or dogs with kidney disease liver disease or known or suspected bleeding disorders.
It is recommended for the control of signs associated with non infectious degenerative and or traumatic arthritis of canine synovial joints.
Furthermore a small percentage of these overdosed dogs showed pain at their injection sites i ve never noticed this in my patients so the discomfort may be related to the larger volumes administered to these test subjects.
For most dogs the benefits of adequan administration greatly outweigh the possible risks.